Stock Research for PMCB


Featured Broker: Ally Invest

Get the due diligence for another stock.


PMCB Stock Chart & Research Data

The PMCB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PMCB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PMCB Due diligence Resources & Stock Charts

The PMCB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PMCB Detailed Price Forecast - CNN Money CNN View PMCB Detailed Summary - Google Finance
Yahoo View PMCB Detailed Summary - Yahoo! Finance Zacks View PMCB Stock Research & Analysis -

Stock Analysis

TradeIdeas View PMCB Trends & Analysis - Trade-Ideas Barrons View PMCB Major Holders - Barrons
NASDAQ View PMCB Call Transcripts - NASDAQ Seeking View PMCB Breaking News & Analysis - Seeking Alpha
Spotlight View PMCB Annual Report - OTC Report View PMCB OTC Short Report -
TradeKing View PMCB Fundamentals - TradeKing Charts View PMCB SEC Filings - Bar Chart
WSJ View Historical Prices for PMCB - The WSJ Morningstar View Performance/Total Return for PMCB - Morningstar
MarketWatch View the Analyst Estimates for PMCB - MarketWatch CNBC View the Earnings History for PMCB - CNBC
StockMarketWatch View the PMCB Earnings - StockMarketWatch MacroAxis View PMCB Buy or Sell Recommendations - MacroAxis
Bullish View the PMCB Bullish Patterns - American Bulls Short Pains View PMCB Short Pain Metrics -

Social Media Mentions

StockTwits View PMCB Stock Mentions - StockTwits PennyStocks View PMCB Stock Mentions - PennyStockTweets
Twitter View PMCB Stock Mentions - Twitter Invest Hub View PMCB Investment Forum News - Investor Hub
Yahoo View PMCB Stock Mentions - Yahoo! Message Board Seeking Alpha View PMCB Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PMCB - Insider Cow View Insider Transactions for PMCB - Insider Cow
CNBC View PMCB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PMCB - OTC Markets
Yahoo View Insider Transactions for PMCB - Yahoo! Finance NASDAQ View Institutional Holdings for PMCB - NASDAQ

Stock Charts

FinViz View PMCB Stock Insight & Charts - StockCharts View PMCB Investment Charts -
BarChart View PMCB Stock Overview & Charts - BarChart Trading View View PMCB User Generated Charts - Trading View

Latest Financial News for PMCB

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
Posted on Wednesday November 15, 2023

LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. This is the Company’s first investment in externally dev

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
Posted on Wednesday November 15, 2023

- $6.85 million upfront investment provides $23 million total cash runway into second half 2025 - - Financing allows for focused commercial team to bring Femasys’ infertility-related products to women in the U.S. - - Additional financing supports the advancement of Femasys’ lead product candidate, FemBloc® for permanent birth control, to initial clinical data readout - ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unme

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
Posted on Tuesday October 31, 2023

LAS VEGAS, October 31, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") provides an update on its investigation of its Cell-in-a-Box technology and initial next steps in development. Following a comprehensive scientific review of amassed data, the Company is in the process of requesting a meeting with the U.S. Food and Drug Administration (FDA) for guidance on further development of the technology. The meeting is expected to occur during the first quarter of 2024. In

PharmaCyte Biotech Announces Final Results of Tender Offer
Posted on Thursday June 15, 2023

LAS VEGAS, June 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender offer to acquire up to 7,750,000 million shares of the Company’s common stock, par value $0.001 per share, at a price of $3.25 per share in cash, less any applicable withholding taxes and without interest. The tender offer expired one minute after 11:59 p.m. on June 9, 2023, and was funded entirely through the Company’s cash on han

Stock Market & Investing Books

Enter a stock symbol to view the stock details.